FOXO4 10 mg
$ 178
FOXO4 10 mg
Find your batch COA to review available test results.
Browse our public COA library—no login needed.
Out of stock
US-based support available Monday - Friday 7-6pm ET
Volume Discounts available on select products
Supported by a Certificate of Analysis.
Intended for laboratory research applications.
Peptides are short chains of amino acids studied for their role in cellular signaling and molecular interactions. In research settings, they are commonly used to explore biological pathways and structure–function relationships.
Across scientific disciplines, peptide research supports advances in biochemistry and molecular biology. Their precision and adaptability make peptides essential tools in modern laboratory research.
Support precise investigation of cellular signaling pathways
Enable targeted structure–function research at the molecular level
Offer high specificity for controlled experimental design
Adapt easily across a wide range of research applications
Aid in studying protein interactions and biological responses
Allow consistent and repeatable laboratory testing
Integrate well with modern analytical and research methods
Serve as foundational tools in biochemical and molecular research
Peptides continue to serve as essential components in modern research due to their flexibility, precision, and well-defined structures. In laboratory settings, researchers rely on peptides to examine biological mechanisms, evaluate molecular interactions, and refine experimental models with a high level of control. Their scalable nature and compatibility with advanced analytical techniques make peptides valuable across both foundational studies and ongoing research development, supporting consistent, reproducible outcomes in controlled scientific environments.
FOXO4-DRI is an experimental peptide studied primarily in preclinical research involving cellular senescence and FOXO4-p53 signaling. It is not an approved therapeutic product.
DRI stands for D-retro-inverso. This peptide-design approach uses D-amino acids in a reversed sequence arrangement to improve resistance to enzymatic degradation while preserving important side-chain positioning.
FOXO4 and p53 are proteins involved in cellular signaling. FOXO4-DRI has been investigated in laboratory models for its ability to disrupt their interaction in certain senescent-cell systems.
Published research largely focuses on cellular senescence, apoptosis-related signaling, aging biology, and mechanisms associated with senescent-cell survival. Current evidence is predominantly preclinical.
No. FOXO4-DRI is not FDA-approved for therapeutic use, and its research literature should not be interpreted as proof of safety or effectiveness in humans.
Nova Pharmaceuticals P.O. Box 21083 Bakersfield, CA 93390
© 2026 Nova Pharmaceuticals. All rights reserved.
Nova Pharma sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.
Not a researcher? Exit
Reviews
There are no reviews yet.